Mechanism of action
Memories are consolidated — not formed — in the hours after trauma. TraumaShield acts on five pathways during that window. Select a pathway to load its model.
Suppresses fear-learning responses (by reducing hyperactivity in the amygdala).
Enhances healthy contextual memory (by enhancing hippocampal neuroplasticity).
Enhances GABAergic inhibitory transmission.
View model →Suppresses excitatory NMDA receptor activity.
View model →Modulates neuroprotective pathways to prevent long-term damage.
View model →
Real-time drug‑device intervention for post‑trauma disorder prevention
Administered during the post-trauma “golden hours” to support healthy memory consolidation.
An FDA-approved, repurposed compound that helps the brain store the event as a past, safe memory instead of an ongoing nightmare.
Delivered through a dedicated, disposable, easy-to-use field device.
Significant reduction in PTSD incidence.
Peer-reviewed.
Independent peer-reviewed study · reference available to qualified partners.
The neuroscientific mechanism explaining why the 0-6 hour window is the critical prevention point. Memories are consolidated — not formed — in this window, making pharmacological intervention uniquely effective.
An existing safety profile removes the need for a traditional Phase I program. The repurposed agent has a well-characterized pharmacokinetic and safety profile from prior clinical use.
Backed by independent peer-reviewed studies. Significant reduction confirmed in independent human data. Reproduced in preclinical models.
"Backed by independent clinical validation and a full scientific package assembled by world-leading experts in psychiatry and neuroscience."
Protected, fast,
field-ready.
A method-of-use patent, an accelerated regulatory pathway, and a form factor built for the field — three defenses that compound.
Protection filed for the second medical use and the combination device architecture.
Streamlined FDA pathway defined and pre-IND package prepared, leveraging existing safety data to accelerate time-to-market.
Engineered for standard IFAK kits and minimal training.